New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that nearly 30% of patients with lupus in a multi-ethnic and multi-racial study had a low response to the new COVID-19 vaccines. Systemic lupus erythematosus (SLE or lupus), is a chronic (long-term) disease that causes systemic inflammation which affects